Formulary Watch |
All News - Page 73
FDA okays targeted leukemia treatment
August 22, 2017
FDA approved a targeted new drug to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
FDA eyes opioids in kids' medicines
August 21, 2017
An FDA committee will review prescription opioid products containing hydrocodone or codeine to treat coughs in children.
Groups praise lawsuit against Walgreens, CVS
August 15, 2017
Pharmacy and medical organizations lauded a new class action lawsuit against CVS Health and Walgreens, alleging the two pharmacy chains colluded with pharmacy benefit managers (PBMs) to drive up the cost of generic drugs.
FDA warns about contaminated drugs, dietary supplements
August 15, 2017
FDA warned consumers and health care professionals not to use a certain brand of drugs and dietary supplements that are contaminated.
DEA wants to slash opioid production
August 7, 2017
The Drug Enforcement Administration wants to slash the production of opioid painkillers by 20% in 2018.
FDA approves novel leukemia, hepatitis C drugs
August 4, 2017
FDA approved the first treatment for patients with a certain type of acute myeloid leukemia, as well as 2 new drugs to treat hepatitis C.
Popular insulin meets target in real-world study
July 14, 2017
Novo Nordisk’s DEVOTE study reveals interesting findings.
New universal companion diagnostic paves the way for precision oncology
July 14, 2017
FDA approves new diagnostic test for non-small cell lung cancer.
FDA approves Bayer’s Bluetooth-enabled auto-injector for multiple sclerosis
July 5, 2017
FDA has approved a supplemental Biologics License Application (sBLA) for Bayer’s myBETAapp and BETACONNECT Navigator for multiple sclerosis (MS) patients
New antibiotic approved for acute bacterial skin infections
July 5, 2017
FDA approved the use of a new fluoroquinolone antibiotic to treat ABSSSI.
FDA to drug maker: Pull opioid pain drug
July 1, 2017
Potential public health consquences prompts FDA to request removal of opioid pain medication.
FDA approves EpiPen rival
July 1, 2017
Adamis’ epinephrine injection promises to be a lower-cost alterative to EpiPen.
FDA approves first generic Truvada for HIV
June 16, 2017
The first generic Truvada for treating and preventing HIV will be available, but when?
FDA gives once-daily HIV therapy go-ahead
June 16, 2017
FDA approves Isentress at a higher dose for HIV-1 infected patients.
Asthma biologic may reduce oral steroid use
June 14, 2017
A new trial for AstraZeneca’s benralizumab shows promising results for severe asthma patients.
First generic Strattera for ADHD approved
June 13, 2017
FDA has approved the first generic versions of Strattera (atomoxetine) for the treatment of attention deficit/hyperactivity disorder.
Investigational drug appears beneficial in preventing migraines
June 6, 2017
Lilly's galcanezumab proves successful in three phase 3 migraine studies. Here are the findings.
Drugmaker recalls samples of antiplatelet drug
June 6, 2017
AstraZeneca voluntarily recalls professional samples of its antiplatelet agent. Here's what to do.
Combination pack approved for breast cancer treatment
June 1, 2017
FDA approves ribociclib plus letrozole to treat a subset of advanced breast cancer patients.
Top 5 specialty drug management issues
May 24, 2017
The 13th edition EMD Serono Specialty Digest outlines top specialty drug management issues health plans face.
How pharma reps impact physician prescribing
May 23, 2017
A new study led by The University of California researchers and published in JAMA reveals surprising findings.
Amputation risk possible with diabetes drugs, FDA warns
May 22, 2017
Based on new data from 2 large clinical trials, FDA is warning that these blockbuster type 2 diabetes medications can cause an increased risk of leg and foot amputations.
FDA expands cystic fibrosis treatment
May 22, 2017
FDA expanded the use of ivacaftor (Kalydeco, Vertex Pharmaceuticals) to treat cystic fibrosis.
New FDA lead ushers in new era
May 16, 2017
Scott Gottlieb, MD, was sworn in as the new FDA commissioner and ushers in a new era.
Immuno-oncology bladder drug wins approval
May 16, 2017
Soon after approving the same drug for metastatic Merkel cell carcinoma, FDA approved immuno-oncology avelumab (Bavencio) for locally advanced or metastatic urothelial carcinoma.
Costly new ALS treatment approved
May 9, 2017
FDA recently approved the first new treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, in more than 20 years.
Campaign gears up to combat high drug prices
May 9, 2017
Walmart, CVS Health, and a number of other healthcare organizations are supporting a new multi-million dollar consumer campaign to combat high prescription drug prices.
FDA approves first targeted leukemia drug for certain patients, plus 2 more
May 2, 2017
Late last week, FDA approved a new drug to treat acute myeloid leukemia (AML), the first treatment for Batten disease, and expanded the use of a current drug to treat liver cancer.
